Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Nina Zdinjak

Breaking: Avicanna's Cannabinoid Drugs To Reach Brazil Via Its First 'Big Pharma' Deal

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development and commercialization of plant-derived medical and pharmaceutical cannabinoid-based products, has entered into an exclusive license and supply agreement with an established South American pharmaceutical company  to commercialize up to four of Avicanna’s proprietary cannabinoid-based pharmaceutical preparations.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.